July 2021 JDD Issue | Special Topic: Skin of Color
With a special focus on patients with skin of color, the July issue of the Journal of Drugs in Dermatology is packed with outstanding articles, features, and case reports on topics ranging from OTC therapies for hair grow and choosing the right sunscreen in communities of color, to evaluation of a skin of color curriculum for dermatology residents and PLLA for correction of nasolabial folds. Stra …
With a special focus on patients with skin of color, the July issue of the Journal of Drugs in Dermatology is packed with outstanding articles, features, and case reports on topics ranging from OTC therapies for hair grow and choosing the right sunscreen in communities of color, to evaluation of a skin of color curriculum for dermatology residents and PLLA for correction of nasolabial folds. Stra … Continue reading "July 2021 JDD Issue | Special Topic: Skin of Color"
Time is at the premium for dermatology trainees, especially those with families.
“Time is the most valuable commodity I have and through my near-decade of training it becomes more important each day,” said dermatology resident Luke Maxfield, DO, a husband and father of two.
Sang Kim, MD, a dermatology resident, husband, and father of two, said, “We are constantly in a cycle of waking u … 
Articles in this month’s Patient Buzz address questions about skincare products and how to use them. Do oils hydrate the skin? Are products with snail slime effective? What ingredients to avoid in homemade skin care? What’s the best way to introduce a new skincare product to your routine?
Be prepared for your patient’s questions about skincare products by reviewing this list of dermatolog … 
Next Steps in Derm author and Derm In-Review Advisory Council member, Dr. Cula Dautriche, reached out to Dr. Daniel Siegel, former president of the American Academy of Dermatology (AAD), to shed some light on some of the challenges facing the field of dermatology today. Dr. Siegel is currently the chair of the Council on Corporate, Community and Philanthropic Relations of the AAD and remains heav … 
So many diseases, so few FDA approved indications. Between the mind-numbing time and cost from bench to bottle, it is no surprise that dermatologists, as masters of the integument are the off-label bandits, marrying their wealth of knowledge on the pathophysiology of skin diseases to the mechanisms by which medications work to create an evidenced-based armament of therapies for both common and rar …